Mercer Global Advisors
GILD icon

Mercer Global Advisors’s Gilead Sciences GILD Stock Holding History

Mercer Global Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.1M Buy
309,147
+12,493
+4% +$1.65M 0.05% 220
2026
Q1 		$41.3M Sell
296,654
-28,381
-9% -$3.97M 0.06% 190
2025
Q4 		$37.3M Buy
325,035
+29,150
+10% +$3.54M 0.06% 211
2025
Q3 		$32.8M Buy
295,885
+54,455
+23% +$6.19M 0.05% 208
2025
Q2 		$26.8M Buy
241,430
+4,677
+2% +$498K 0.05% 188
2025
Q1 		$26.5M Buy
236,753
+8,286
+4% +$855K 0.06% 176
2024
Q4 		$21.1M Sell
228,467
-355,197
-61% -$32M 0.05% 205
2024
Q3 		$49M Buy
583,664
+351,966
+152% +$26.9M 0.11% 107
2024
Q2 		$12.6M Sell
231,698
-124,073
-35% -$8.28M 0.03% 260
2024
Q1 		$26.1M Buy
355,771
+31,485
+10% +$2.42M 0.07% 163
2023
Q4 		$26.3M Buy
324,286
+12,554
+4% +$977K 0.08% 161
2023
Q3 		$23.4M Buy
311,732
+44,015
+16% +$3.39M 0.09% 144
2023
Q2 		$20.6M Buy
267,717
+31,208
+13% +$2.49M 0.08% 167
2023
Q1 		$19.6M Buy
236,509
+36,818
+18% +$3.05M 0.09% 163
2022
Q4 		$17.1M Buy
199,691
+105,214
+111% +$8.33M 0.09% 175
2022
Q3 		$5.83M Buy
94,477
+12,828
+16% +$809K 0.03% 341
2022
Q2 		$5.05M Sell
81,649
-1,358
-2% -$84.1K 0.03% 365
2022
Q1 		$4.93M Buy
83,007
+10,543
+15% +$674K 0.03% 385
2021
Q4 		$5.26M Buy
72,464
+7,216
+11% +$497K 0.03% 359
2021
Q3 		$4.56M Buy
65,248
+3,471
+6% +$244K 0.03% 369
2021
Q2 		$4.25M Buy
61,777
+1,585
+3% +$106K 0.03% 360
2021
Q1 		$3.89M Buy
60,192
+19,070
+46% +$1.23M 0.04% 349
2020
Q4 		$2.4M Sell
41,122
-10,235
-20% -$618K 0.03% 380
2020
Q3 		$3.25M Buy
51,357
+430
+0.8% +$29.8K 0.05% 277
2020
Q2 		$3.92M Sell
50,927
-4,866
-9% -$373K 0.07% 200
2020
Q1 		$4.17M Sell
55,793
-35,738
-39% -$2.47M 0.09% 189
2019
Q4 		$5.95M Buy
91,531
+4,857
+6% +$316K 0.12% 151
2019
Q3 		$5.49M Buy
86,674
+43,564
+101% +$2.85M 0.13% 144
2019
Q2 		$2.91M Buy
43,110
+118
+0.3% +$7.76K 0.08% 208
2019
Q1 		$2.79M Buy
+42,992
New +$2.86M 0.1% 180

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mercer Global Advisors's GILD Position: Q2 2026 in Review

Mercer Global Advisors increased its Gilead Sciences (GILD) stake by 4.2% in Q2 2026, buying an estimated $1.65M and bringing the position to 309,147 shares worth $39.1M. The position accounts for 0.05% of the portfolio, ranked #220.

Mercer Global Advisors first reported a position in GILD in Q1 2019 and has held it in 30 quarters since. The position peaked at $49M in Q3 2024. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mercer Global Advisors held 309,147 shares of Gilead Sciences worth $39.1M as of Q2 2026.
  • Mercer Global Advisors bought 12,493 Gilead Sciences shares in Q2 2026, an estimated $1.65M.
  • Gilead Sciences made up 0.05% of Mercer Global Advisors's portfolio in Q2 2026, its #220 holding.
  • Mercer Global Advisors first reported a position in Gilead Sciences in Q1 2019 and has held it in 30 quarters since.
  • Mercer Global Advisors's Gilead Sciences position peaked at $49M in Q3 2024.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.